Amanta Healthcare IPO Allotment Status: Check Latest GMP, Steps to Verify Status
The bidding window for the Amanta Healthcare IPO closed on September 3, 2025, for public subscription. The allotment process is expected to be finalised today on September 4, 2025, and the company’s shares will be listed on both BSE and NSE. The tentative listing date is fixed as September 9, 2025.
Procedure to Check Amanta Healthcare IPO Allotment Status Online On BSE
- Click here to visit the application status page.
- In Issue Type, “Equity”.
- In Issue Name, select “Amanta Healthcare Ltd”.
- Enter your “Application No.” or “PAN No.”
- Click on “I am not a robot”.
- Click “Submit”.
Procedure to Check Amanta Healthcare IPO Allotment Status on NSE
- Visit the NSE’s IPO allotment verification status page here.
- Select “Equity & SME IPO bid details”.
- In Select Symbol, select “Amanta Healthcare Ltd”.
- Enter your PAN No. and application No.
- Click “Submit”.
Procedure to Check Amanta Healthcare IPO Allotment Status on MUFG Intime India Private Limited (Registrar to the issue)
- Click here to visit MUFG Intime’s application status page.
- Under, Please select company, select “Amanta Healthcare Ltd”.
- Enter any of the following details.
-
- PAN
- App. No.
- DP/Client ID
- Account No / IFSC
- Click “Submit”.
Amanta Healthcare - IPO Details
Amanta Healthcare was a bookbuilding consisting entirely of a fresh issue of 1 crore equity shares. The issue price band was set at ₹120 to ₹126 per share. The minimum lot size for an application was 119, and the minimum investment amount required for a retail investor is ₹14,994 (119 shares).
Beeline Capital Advisors Pvt.Ltd was the book-running lead manager, and MUFG Intime India Pvt.Ltd was the registrar for the Amanta Healthcare IPO.
Amanta Healthcare IPO Overall Subscription Status
(September 3, 2025, 07:00 P.M )
On Day 3, Amanta Healthcare's IPO saw a subscription of 82.61 times the offer size. The public issue was subscribed 54.98 times in the retail category, 35.86 times in the QIB category, and 209.42 times in the NII category.
Explore other Upcoming IPOs on BSE and NSE.
Amanta Healthcare GMP Details
According to Investorgain, the Grey Market Premium (GMP) of Amanta Healthcare is ₹8.50 as of September 4, 2025, 05:56 a.m. This indicates that the estimated listing price can be ₹134.50 as per the upper price band, which is ₹126. The estimated gain per share is 6.75%.
|
Source: Investorgain Media Report dated September 4, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
About Amanta Healthcare Ltd
Amanta Healthcare Ltd., founded in 1994 in Ahmedabad, is a pharmaceutical company that manufactures sterile liquid medicines, including injections, eye drops, respiratory solutions, and irrigation fluids. It employs advanced technologies like Blow-Fill-Seal (BFS) to ensure high quality.
The company has a wide portfolio of more than 45 generic medicines supplied in India and abroad. Its large manufacturing facility in Gujarat is WHO-GMP certified and equipped with modern production lines for both large and small-volume injectables. In FY25, Amanta recorded a revenue of ₹276 crore with a net profit of ₹10.5 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here